Declared technologies base

TRANSFER OF INNOVATIONAL TECHNOLOGIES

BIOSENGTH SYSTEM FOR DETERMINATION OF UREA AND CREATININ


Purpose of the development: The system is designed to diagnose kidney function and control the quality of hemodialysis.

Recommended application field: The medicine.

Technical characteristic: Indicator bioselective element based   Creatinide-recombinant                                                                                         aminase urease Analit Creatinine Urea. Linear range of determination, mmol 0.02-2.0 0.5-20. Operating stability, h 8 8. Stability during storage, months 5 5. Analysis, min 5-7 5-7. Measurement error,% <= 5 <= 5.

Advantages over analogues: There are no commercial analogues of the system. The proposed system differs from the known methods for the determination of creatinine and urea in that it does not require preliminary sample preparation, has a short analysis time (express analysis), low labor intensity and cost of analysis, high sensitivity and selectivity of determination, the possibility of simultaneous determination of both metabolites in real time at the bedside

The development stage readiness: Ready for application

Information about newness of the development:
there are Ukrainian patents -- 1 items

corresponds technical description
Ready for implementation

Possibility of transfer abroad:
Combinated reduction to industrial level
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua

or fill out the form:
Organization name :
Address :
Settlement account :
Bank :
MFO :
OKPO code :

Scientific organization tutor's data :
Surname :
Name :
Patronymic :
Scientific degree :
Phone :
Fax :
E-mail :
Cooperation proposals (joint patent, joint enterprise, assembly sale and so on :
country: